Back to SEC FilingsView Full Filing on SEC.govBrowse More Filings
Watching Vir Biotechnology, Inc.? See every signal: funding, hires, M&A, contracts, sentiment.
Book a demoChoose your planAI Executive Summary
AI-powered analysis of 10-Q filing content
Basic analysis: 3 risks, 1 positives detected.
Red Flags Detected (3)
Litigation
Impairment
Restructuring
Filing Overview
Form TypeQuarterly Report (10-Q)
Filing DateAug 5, 2026
Risk LevelMEDIUM
TrendSTABLE
AI Confidence40%
Red Flags3
What This Means
Quarterly Report: Interim filing with unaudited financial data for the quarter.